Countable Labs

1 known investors

Countable Labs (formerly Enumerix) develops Countable PCR (formerly UltraPCR), a digital PCR platform using ~30 million partitions to deliver higher sensitivity, precision, and dynamic range than legacy dPCR/ddPCR methods. Its technology is applied to oncology assays, cell and gene therapy, NIPT, and infectious disease testing.